Used in research settings as a selective agonist for the GPR139 receptor, which is involved in modulating neurotransmitter release in the central nervous system. It serves as a tool compound to study receptor function and signaling pathways linked to neurological and psychiatric disorders. Due to its high selectivity, it helps scientists investigate potential therapeutic targets for conditions such as schizophrenia, depression, and addiction. Not intended for clinical use or human consumption.